Liposomal Irinotecan Oxaliplatin, 5-Fluorouracil/Calcium Folinate in Combination With Camrelizumab for Borderline Resectable Pancreatic Cancer: a Prospective, Exploratory Study
Latest Information Update: 09 Apr 2024
At a glance
- Drugs Camrelizumab (Primary) ; Fluorouracil (Primary) ; Folinic acid (Primary) ; Irinotecan (Primary) ; Oxaliplatin (Primary)
- Indications Pancreatic cancer; Pancreatic ductal carcinoma
- Focus Therapeutic Use
Most Recent Events
- 09 Apr 2024 New trial record